CN29: The use of patient reported outcome (PRO) instruments in immune checkpoint inhibitor (ICI) therapy for cancer: A systematic review
Colomer-Lahiguera S., Bryant-Lukosius D., Rietkoetter S., Martelli L., Ribi K., Orcurto A., Juergens R., Eicher M., 2018/10., 43rd ESMO Congress (ESMO) pp. viii690 dans Annals of Oncology.
ici le détail
